These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15289308)

  • 1. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
    Guan B; Yue P; Clayman GL; Sun SY
    J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
    Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
    Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the human death receptor 4 is regulated by activator protein 1.
    Guan B; Yue P; Lotan R; Sun SY
    Oncogene; 2002 May; 21(20):3121-9. PubMed ID: 12082627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
    Mukhopadhyay T; Roth JA
    Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
    Mendoza FJ; Ishdorj G; Hu X; Gibson SB
    Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway.
    Li C; Chen H; Ding F; Zhang Y; Luo A; Wang M; Liu Z
    Biochem J; 2009 Aug; 422(2):363-72. PubMed ID: 19534726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
    Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.
    Lee Y; Chen Y; Chang LS; Johnson LF
    Exp Cell Res; 1997 Aug; 234(2):270-6. PubMed ID: 9260894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I; Marciniak RA
    Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
    Sun M; Zhang J; Liu S; Liu Y; Zheng D
    Oncol Rep; 2008 Jan; 19(1):177-85. PubMed ID: 18097593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
    Yang AL; Festing MF
    Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.